retatrutide triple agonist glp-1 gip glucagon receptor From Obesity to Metabolic Health: Why Is a Game-Changer Retatrutide Explained: How the Triple

Warnick, K

[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Wang Y., Chen R., Wa Y., Ding S., Yang Y., Liao J., Tong L., Xiao G

Long-term safety monitoring is still important because retatrutide may cause significant weight loss and affects several hormone pathways

Patient preference and experience should guide final selection

A 10mg vial, 2mL of bacteriostatic water, a U-100 insulin syringe

#DrugInteractionSeries #ClinicalPharmacy #PharmD #MedicationSafety #PatientSafety #Pharmacology #Cardiology To view or add a comment, sign in 20% weight loss in 48 weeks !! non-GLP-1/non-GIP medication Eloralintide By Eli Lilly